Logo image of ALTO

ALTO INGREDIENTS INC (ALTO) Stock Fundamental Analysis

NASDAQ:ALTO - Nasdaq - US0215131063 - Common Stock - Currency: USD

1.17  +0.07 (+6.36%)

After market: 1.17 0 (0%)

Fundamental Rating

2

ALTO gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 85 industry peers in the Chemicals industry. ALTO may be in some trouble as it scores bad on both profitability and health. ALTO has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year ALTO has reported negative net income.
ALTO had a negative operating cash flow in the past year.
ALTO had negative earnings in 4 of the past 5 years.
ALTO had a positive operating cash flow in 4 of the past 5 years.
ALTO Yearly Net Income VS EBIT VS OCF VS FCFALTO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M

1.2 Ratios

ALTO has a Return On Assets of -14.97%. This is in the lower half of the industry: ALTO underperforms 78.82% of its industry peers.
With a Return On Equity value of -28.14%, ALTO is not doing good in the industry: 74.12% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -14.97%
ROE -28.14%
ROIC N/A
ROA(3y)-10.14%
ROA(5y)-4.95%
ROE(3y)-17.06%
ROE(5y)-8.78%
ROIC(3y)N/A
ROIC(5y)N/A
ALTO Yearly ROA, ROE, ROICALTO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20 -30 -40

1.3 Margins

Looking at the Gross Margin, with a value of 1.08%, ALTO is doing worse than 89.41% of the companies in the same industry.
In the last couple of years the Gross Margin of ALTO has declined.
The Profit Margin and Operating Margin are not available for ALTO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 1.08%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-43.6%
GM growth 5YN/A
ALTO Yearly Profit, Operating, Gross MarginsALTO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 -2 4 -4 -6

More info and screens

3

2. Health

2.1 Basic Checks

ALTO does not have a ROIC to compare to the WACC, probably because it is not profitable.
ALTO has more shares outstanding than it did 1 year ago.
The number of shares outstanding for ALTO has been increased compared to 5 years ago.
ALTO has a worse debt/assets ratio than last year.
ALTO Yearly Shares OutstandingALTO Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
ALTO Yearly Total Debt VS Total AssetsALTO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

Based on the Altman-Z score of -0.13, we must say that ALTO is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of ALTO (-0.13) is worse than 83.53% of its industry peers.
A Debt/Equity ratio of 0.52 indicates that ALTO is somewhat dependend on debt financing.
ALTO has a better Debt to Equity ratio (0.52) than 64.71% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.52
Debt/FCF N/A
Altman-Z -0.13
ROIC/WACCN/A
WACC10.06%
ALTO Yearly LT Debt VS Equity VS FCFALTO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

A Current Ratio of 2.89 indicates that ALTO has no problem at all paying its short term obligations.
ALTO has a Current ratio of 2.89. This is amongst the best in the industry. ALTO outperforms 83.53% of its industry peers.
ALTO has a Quick Ratio of 1.94. This is a normal value and indicates that ALTO is financially healthy and should not expect problems in meeting its short term obligations.
ALTO has a Quick ratio of 1.94. This is in the better half of the industry: ALTO outperforms 77.65% of its industry peers.
Industry RankSector Rank
Current Ratio 2.89
Quick Ratio 1.94
ALTO Yearly Current Assets VS Current LiabilitesALTO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

More info and screens

3

3. Growth

3.1 Past

ALTO shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -115.79%.
ALTO shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -17.26%.
The Revenue has been decreasing by -7.49% on average over the past years.
EPS 1Y (TTM)-115.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%5.88%
Revenue 1Y (TTM)-17.26%
Revenue growth 3Y-7.2%
Revenue growth 5Y-7.49%
Sales Q2Q%-5.87%

3.2 Future

ALTO is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 34.90% yearly.
The Revenue is expected to grow by 12.23% on average over the next years. This is quite good.
EPS Next Y55.76%
EPS Next 2Y46.96%
EPS Next 3Y34.9%
EPS Next 5YN/A
Revenue Next Year-2.41%
Revenue Next 2Y2.51%
Revenue Next 3Y12.23%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ALTO Yearly Revenue VS EstimatesALTO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
ALTO Yearly EPS VS EstimatesALTO Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 -1 2 3

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

ALTO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 8.82 indicates a reasonable valuation of ALTO.
Based on the Price/Forward Earnings ratio, ALTO is valued cheaper than 87.06% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.13. ALTO is valued rather cheaply when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 8.82
ALTO Price Earnings VS Forward Price EarningsALTO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ALTO is valued a bit more expensive than 75.29% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 26.94
ALTO Per share dataALTO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ALTO's earnings are expected to grow with 34.90% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y46.96%
EPS Next 3Y34.9%

More info and screens

0

5. Dividend

5.1 Amount

ALTO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ALTO INGREDIENTS INC

NASDAQ:ALTO (6/13/2025, 8:00:01 PM)

After market: 1.17 0 (0%)

1.17

+0.07 (+6.36%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)05-07 2025-05-07/amc
Earnings (Next)08-04 2025-08-04/amc
Inst Owners36.77%
Inst Owner Change-11.36%
Ins Owners4.89%
Ins Owner Change5.24%
Market Cap90.34M
Analysts82.5
Price Target4.08 (248.72%)
Short Float %1.09%
Short Ratio1.61
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.02
Dividend Growth(5Y)-2.34%
DP-2.1%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-182.18%
Min EPS beat(2)-385.93%
Max EPS beat(2)21.57%
EPS beat(4)2
Avg EPS beat(4)-131.36%
Min EPS beat(4)-385.93%
Max EPS beat(4)50.98%
EPS beat(8)3
Avg EPS beat(8)-78.35%
EPS beat(12)4
Avg EPS beat(12)-1064.23%
EPS beat(16)5
Avg EPS beat(16)-813.08%
Revenue beat(2)1
Avg Revenue beat(2)2.01%
Min Revenue beat(2)-0.06%
Max Revenue beat(2)4.09%
Revenue beat(4)1
Avg Revenue beat(4)-1%
Min Revenue beat(4)-7.73%
Max Revenue beat(4)4.09%
Revenue beat(8)4
Avg Revenue beat(8)0.19%
Revenue beat(12)7
Avg Revenue beat(12)1.3%
Revenue beat(16)10
Avg Revenue beat(16)2.16%
PT rev (1m)-11.11%
PT rev (3m)-11.11%
EPS NQ rev (1m)-16.67%
EPS NQ rev (3m)-362.5%
EPS NY rev (1m)-20%
EPS NY rev (3m)-275.61%
Revenue NQ rev (1m)-4.69%
Revenue NQ rev (3m)-9.03%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-9.1%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 8.82
P/S 0.09
P/FCF N/A
P/OCF N/A
P/B 0.42
P/tB 0.44
EV/EBITDA 26.94
EPS(TTM)-0.82
EYN/A
EPS(NY)0.13
Fwd EY11.33%
FCF(TTM)-0.39
FCFYN/A
OCF(TTM)-0.3
OCFYN/A
SpS12.32
BVpS2.77
TBVpS2.67
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -14.97%
ROE -28.14%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 1.08%
FCFM N/A
ROA(3y)-10.14%
ROA(5y)-4.95%
ROE(3y)-17.06%
ROE(5y)-8.78%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-43.6%
GM growth 5YN/A
F-Score2
Asset Turnover2.36
Health
Industry RankSector Rank
Debt/Equity 0.52
Debt/FCF N/A
Debt/EBITDA 17.66
Cap/Depr 27.88%
Cap/Sales 0.73%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.89
Quick Ratio 1.94
Altman-Z -0.13
F-Score2
WACC10.06%
ROIC/WACCN/A
Cap/Depr(3y)107.88%
Cap/Depr(5y)83.14%
Cap/Sales(3y)2.13%
Cap/Sales(5y)1.7%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-115.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%5.88%
EPS Next Y55.76%
EPS Next 2Y46.96%
EPS Next 3Y34.9%
EPS Next 5YN/A
Revenue 1Y (TTM)-17.26%
Revenue growth 3Y-7.2%
Revenue growth 5Y-7.49%
Sales Q2Q%-5.87%
Revenue Next Year-2.41%
Revenue Next 2Y2.51%
Revenue Next 3Y12.23%
Revenue Next 5YN/A
EBIT growth 1Y-15.02%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year154.6%
EBIT Next 3Y64.22%
EBIT Next 5YN/A
FCF growth 1Y58.93%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y18.26%
OCF growth 3YN/A
OCF growth 5YN/A